ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

October 29, 2004

NCAB Accepts Plan for Organ Systems Program, Remains Split On Some Issues

February 11, 1983

In Brief: Morton Leaves UCLA Surgical Oncology; Rall Resigns As NIH Deputy for Intramural Research

May 17, 1991

Colorectal, Lung Cancer Screening Techniques Show No Mortality Improvement, Conferences Find

December 1, 1978

Funding opportunities listed.

February 13, 2004

ODACSupports Temodal For Treatment of Astrocytoma

January 22, 1999